Effects of vitamin E administration on APACHE II score in ARDS patients

Daru

Volumn 17, Issue 1, 2009, Pages 24-28

  Hajimahmoodi, M ^a   Mojtahedzadeh, M ^a   GhaffarNatanzi, N ^a   Sadrai, S ^a   Sadeghi, N ^a   Nadjafi, A ^b   Hadadi, A ^b   Oveisi, M R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute respiratory distress syndrome; APACHE II score; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; SODIUM CHLORIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANT ACTIVITY; APACHE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; GENERAL CONDITION IMPROVEMENT; HOSPITAL PATIENT; HUMAN; MALE; OXIDATIVE STRESS; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 62649148372     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818- 824.
2. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of Acute Lung Injury in the United States. Crit Care Med 2003; 31(6):1607-1611.
3. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155: 1187-1205.
4. Lovat R, Preiser JC. Antioxidant therapy in intensive care. Curr Opin Crit Care 2003; 9(4): 266- 270.
5. Vazin A, Mojtahedzadeh M, Salehifar E. Future drugs for treatment of acute respiratory distress syndrome. Int J Pharmacol 2005; 1: 9-16.
6. Zilberberg MD, Epstein SK. Acute Lung Injury in the medicinal ICU. Am J Respir Crit Care Med 1998; 57: 1159-1164.
7. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25(2): 134-136.
8. Richard C, Lemonnier F, Thibault M, Couturier M, Auzepy P. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med 1990; 18(1): 4-9.
9. Bertrand Y, Pincemail J, Hanique G. Diffrences in tocopherol-lipid ratios in ARDS and non ARDS patients. Intensive Care Med 1989; 15(2): 87- 93.
10. Seeger W, Ziegler A, Wolf HR. Serum alpha-tocopherol levels after high-dose enteral vitamin E administration in patients with acute respiratory failure. Intensive Care Med 1987; 13(6): 395- 400.
11. Nathens AB, Neff MJ, Jurkovich GJ. Randomized prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236(6): 814- 822.
12. Preiser JC, Van Gossum A, Berre J, Vincent JL, Carpentier Y. Enteral feeding with a solution enriched with antioxidant vitamin A, C, and E enhances the resistances to oxidative stress. Crit Care Med 2000; 28(12): 3828-3832.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 3(10): 818- 829.
14. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
15. Rudiger M, Von-Baehr A, Haupt R, Wauer RR, Rustow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit Care Med 2000; 28: 1572- 1577.
16. Kolleck I, Sinha P, Rüstow B. Vitamin E as an Antioxidant of the Lung: Mechanisms of Vitamin E Delivery to Alveolar Type II Cells. Am J Respir Crit Care Med 2002; 166: 62S-66S.
17. Crimi E, Liguori A, Condorelli M, Cioffi M, Astuto M, Bontempo P, Pignalosa O, Vietri MT, Molinari AM, Sica V, Della Corte F, Napoli C. The Beneficial Effects of Antioxidant Supplementation in Enteral Feeding in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Anesth Analg 2004; 99(1): 857-863.
18. Combs GF, The vitamins, fundamental aspects in nutrition and health. Second edition, Academic press; 1998.
19. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148: 1174-1178.
20. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114: 1653-1659.
21. Schmidt R, Luboeinski T, Markart P. Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur Respir J 2004; 24: 994-999.
22. Sadegh Soltan-sharifi M, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, Mohammadirad A, Abdollahi M. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol 2007; 26: 697-703.